Entyvio (vedolizumab)

Wadatacce

• Menene Entyvio?
• Inganci
• Entyvio gama gari
• Entyvio sakamako masu illa
• Commonarin sakamako masu illa na kowa
• M sakamako mai tsanani
• Bayanin sakamako na gefe
• PML
• Rashin gashi
• Karuwar nauyi
• Entyvio yayi amfani
• Entyvio don ciwon ulcerative colitis
• Amfani don magance ulcerative colitis
• Entyvio don cutar Crohn
• Inganci don magance cutar Crohn
• Entyvio ga yara
• Entyvio sashi
• Entyvio dosing jadawalin
• Menene idan na rasa kashi?
• Shin zan buƙaci amfani da wannan maganin na dogon lokaci?
• Alurar riga kafi
• Madadin zuwa Entyvio
• Entyvio vs. Tunawa
• Yi amfani da
• Sigogin ƙwayoyi
• Sakamakon sakamako da kasada
• Inganci
• Kudin
• Entyvio vs. Humira
• Yana amfani da
• Sigogin ƙwayoyi
• Sakamakon sakamako da kasada
• Inganci
• Kudin
• Entyvio da barasa
• Entyvio hulɗa
• Entyvio da sauran magunguna
• Magunguna waɗanda zasu iya hulɗa tare da Entyvio
• Entyvio da rigakafin rayuwa
• Yadda ake shirya don jigilar Entyvio
• Kafin nadinku
• Abin da ake tsammani
• Ta yaya Entyvio ke aiki
• Entyvio da ciki
• Entyvio da nono
• Tambayoyi gama gari game da Entyvio
• Shin Entyvio ilimin halittu ne?
• Har yaushe Entyvio ke aiki?
• Shin za ku iya ɗaukar Entyvio idan kuna yin tiyata?
• Gargadin Entyvio

Menene Entyvio?

Entyvio (vedolizumab) magani ne na sayan magani wanda ake kira da suna. Yawanci ana amfani dashi don magance matsakaicin-ulcerative colitis (UC) ko cutar Crohn a cikin mutanen da basu da wadataccen ci gaba daga wasu magunguna.

Entyvio magani ne na ilimin halittu wanda yake daga nau'ikan magungunan da ake kira antagonists masu karɓar mahaɗa. Ya zo azaman mafita wanda aka bayar ta hanyar jijiya (IV).

Inganci

Don bayani game da tasirin Entyvio, duba sashin "Entyvio yana amfani" a ƙasa.

Entyvio gama gari

Entyvio yana dauke da maganin vedolizumab. Ba a samun Vedolizumab azaman magani na gama gari. Ana samun sa ne kawai kamar Entyvio.

Entyvio sakamako masu illa

Entyvio na iya haifar da lahani ko mummunan sakamako mai illa. Jerin na gaba yana ƙunshe da wasu mahimman abubuwan illa da zasu iya faruwa yayin shan Entyvio. Wannan jerin ba ya haɗa da duk illa mai illa.

Don ƙarin bayani game da yuwuwar illa na Entyvio, ko nasihu kan yadda za'a magance matsalar illa, yi magana da likitanka ko likitan magunguna.

Commonarin sakamako masu illa na kowa

Abubuwan da suka fi dacewa na yau da kullun na Entyvio sun haɗa da:

• hanci mai zafin gaske
• ciwon wuya
• cututtukan numfashi kamar su mashako ko cutar sinus
• ciwon kai
• ciwon gwiwa
• tashin zuciya
• zazzaɓi
• gajiya
• tari
• mura
• ciwon baya
• kurji ko fata mai kaushi

M sakamako mai tsanani

Kira likitanku nan da nan idan kuna da mummunar illa. Kira 911 idan alamunku suna jin barazanar rai ko kuma idan kuna tunanin kuna samun gaggawa na likita. M sakamako masu illa da alamomin su na iya haɗawa da masu zuwa:

• Maganin rashin lafiyan. Wasu mutane na iya yin rashin lafiyan lokacin da aka ba Entyvio. Waɗannan yawanci ba su da tsanani, amma na iya zama masu tsanani a wasu yanayi. Gudanarwar Entyvio za a buƙaci dakatar da shi idan mummunan yanayi ya faru. Kwayar cututtukan rashin lafiyan na iya haɗawa da:
  • matsalar numfashi
  • fata mai ƙaiƙayi
  • wankewa
  • kurji
• Lalacewar hanta. Wasu mutanen da suka karɓi Entyvio na iya fuskantar lalacewar hanta. Idan kun ci gaba da alamun cutar hanta, likitanku na iya dakatar da maganin ku tare da Entyvio. Kwayar cututtuka na lalata hanta na iya haɗawa da:
  • raunin fata ko fararen idanun ki
  • gajiya
  • ciwon ciki
• Ciwon daji. Yayin karatun Entyvio, kimanin kaso 0.4 cikin ɗari na waɗanda suka karɓi Entyvio sun kamu da cutar kansa idan aka kwatanta da kusan kashi 0.3 cikin ɗari da suka karɓi wuribo. Ko Entyvio yana ƙara haɗarin cutar kansa bai bayyana ba.
• Cututtuka. Mutanen da ke ɗaukar Entyvio suna da haɗarin kamuwa da cuta, irin su sanyi ko mura. Har ila yau, ƙarin cututtuka masu tsanani na iya faruwa. Wadannan na iya hada da tarin fuka ko wata cuta a cikin kwakwalwa da ake kira m multifocal leukoencephalopathy (duba ƙasa). Idan ka sami kamuwa da cuta mai tsanani yayin shan Entyvio, zaka iya dakatar da shan maganin har sai an magance cutar.

Bayanin sakamako na gefe

Kuna iya mamakin yadda sau da yawa wasu cututtukan illa ke faruwa tare da wannan magani. Anan ga wasu dalla-dalla kan wasu cututtukan da wannan maganin zai iya haifarwa.

PML

Ci gaba da yaduwar cutar sankara (PML) babban ciwo ne na kwayar cuta ta kwakwalwa. Yawanci yakan faru ne kawai a cikin mutanen da tsarin garkuwar jikinsu ba ya aiki sosai.

Yayin karatun, PML bai faru a cikin duk wanda ya ɗauki Entyvio ba. Koyaya, ya faru a cikin mutanen da ke karɓar magunguna waɗanda suke kama da Entyvio, kamar su Tysabri (natalizumab).

Yayinda kake ɗaukar Entyvio, likitanka zai kula da kai don bayyanar cututtukan PML. Wadannan alamun na iya haɗawa da:

• rauni a gefe ɗaya na jikinku
• matsalolin hangen nesa
• dimauta
• matsalolin ƙwaƙwalwa
• rikicewa

Idan kuna da tambayoyi ko damuwa game da wannan tasirin, kuyi magana da likitanku ko likitan magunguna.

Rashin gashi

Rashin gashi ba sakamako bane wanda ya faru a cikin karatun Entyvio. Koyaya, wasu mutane sun sami asarar gashi yayin shan Entyvio. Ba a bayyana ba idan Entyvio ce sanadin asarar gashi. Idan kuna da tambayoyi ko damuwa game da wannan tasirin, kuyi magana da likitanku ko likitan magunguna.

Karuwar nauyi

Karuwar nauyi ba sakamako ne na gefen da ya faru a cikin karatun Entyvio ba. Koyaya, wasu mutane da suke ɗaukar Entyvio suna cewa suna ƙaruwa. Samun nauyi na iya zama sakamakon warkarwa a cikin hanji, musamman ga waɗanda suka rasa nauyi saboda ɓarkewar alamun alamun yanayin da ake bi. Idan kuna da tambayoyi ko damuwa game da karɓar nauyi yayin jiyya, yi magana da likitanku ko likitan magunguna.

Entyvio yayi amfani

Cibiyar Abinci da Magunguna (FDA) ta amince da magungunan ƙwayoyi irin su Entyvio don magance wasu sharuɗɗa.

Entyvio an yarda da FDA don magance yanayi biyu: ulcerative colitis (UC) da cutar Crohn.

Entyvio don ciwon ulcerative colitis

Ana amfani da Entyvio don inganta bayyanar cututtuka kuma yana haifar da gafarar bayyanar cututtuka a cikin mutanen da ke da matsakaici-zuwa-mai tsanani UC. An tsara shi don mutanen da ba su da isasshen ci gaba tare da wasu magunguna, ko waɗanda ba za su iya shan wasu magunguna ba.

Amfani don magance ulcerative colitis

Don UC, karatun asibiti sun gano Entyvio yana da tasiri wajen haifar da gafarar bayyanar cututtuka.

Sharuɗɗa daga Gungiyar Gastroenterological Association ta Amurka sun ba da shawarar yin amfani da wakili na ilimin halittu kamar vedolizumab (ƙwaya mai aiki a cikin Entyvio) don jawowa da kuma kulawa da gafara ga manya da matsakaici zuwa mai tsanani UC.

Entyvio don cutar Crohn

Ana amfani da Entyvio don inganta bayyanar cututtuka da haifar da gafartawar bayyanar cututtuka a cikin mutanen da ke da matsakaiciyar-mai-tsanani cutar Crohn. An tsara shi don mutanen da ba su da isasshen ci gaba tare da wasu magunguna, ko waɗanda ba za su iya shan wasu magunguna ba.

Inganci don magance cutar Crohn

Don cutar ta Crohn, karatun asibiti sun gano Entyvio yana da tasiri wajen kawo rashi bayyanar cututtuka.

Sharuɗɗa daga Kwalejin Gastroenterology na Amurka sun ba da shawarar vedolizumab (magani mai aiki a cikin Entyvio) don haifar da gafara da warkar da hanji a cikin manya tare da matsakaici zuwa mai tsanani cutar Crohn.

Entyvio ga yara

Entyvio ba FDA ta amince da ita ba don yara. Koyaya, wasu likitoci na iya amfani da lakabin Entyvio don magance cutar UC ko Crohn a cikin yara.

Studyaya daga cikin binciken ya gano cewa Entyvio ta haifar da gafartawar alamomi a cikin kashi 76 cikin ɗari na yara masu cutar UC, da kuma kashi 42 cikin ɗari na yara masu fama da cutar ta Crohn.

Entyvio sashi

Bayani mai zuwa yana bayanin abubuwan da ake amfani dasu ko aka ba da shawarar. Koyaya, tabbatar da shan maganin da likitanka yayi maka. Likitan ku zai ƙayyade mafi kyawun sashi don dacewa da bukatun ku.

Entyvio dosing jadawalin

Ana gudanar da Entyvio ta hanyar jijiyoyin jini (IV), wanda ke nufin an saka shi a hankali cikin jijiyarka. Jiko shine tsarin kula da magani a cikin jini a cikin wani lokaci.

Ga kowane magani, ana ba da kashi 300 na MG tsawon lokaci na kusan minti 30. An fara jiyya bisa ga wannan jadawalin:

• Makon 0 (makon farko): sashi na farko
• Makon 1: babu kashi
• Makon 2: kashi na biyu
• Sati na 6: kashi na uku

Bayan wannan farkon lokacin na makonni shida, wanda ake kira jawo hankali, ana amfani da jadawalin allurar kulawa. A lokacin yin aikin gyara, ana ba Entyvio kowane mako takwas.

Menene idan na rasa kashi?

Wannan likita za a ba ku. Idan ka rasa alƙawarinka don karɓar kashi naka, kira ofishin likitanka nan da nan don sake tsara lokacin maganin ka.

Shin zan buƙaci amfani da wannan maganin na dogon lokaci?

Haka ne, ana buƙatar amfani da Entyvio don magani na dogon lokaci.

Alurar riga kafi

Kafin fara Entyvio, zaka buƙaci zama mai wadatuwa da tsarin rigakafin da aka bada shawara. Yi magana da likitanka game da samun kowace rigakafin da kake buƙata kafin ka fara jiyya da Entyvio.

Madadin zuwa Entyvio

Akwai magunguna daban-daban da ake amfani dasu don magance ulcerative colitis (UC) da cutar Crohn. Wadannan wasu kwayoyi za'a iya daukar su madadin Entyvio.

Entyvio magani ne na ilmin halitta wanda yawanci ana amfani dashi don magance cutar UC da Crohn lokacin da wasu magunguna basu taimaka alamun ba sosai, ko kuma idan sun haifar da sakamako mai illa. Misalan sauran magungunan ilimin halittu da ake amfani dasu don magance cutar UC ko cutar Crohn sun hada da:

• natalizumab (Tysabri), mai adawa da karɓar mai karɓar mahaɗa
• ustekinumab (Stelara), mai shiga tsakani IL-12 da IL-23 antagonist
• tofacitinib (Xeljanz), mai hana Janus kinase
• ƙari necrosis factor (TNF) -alpha hana kamar:
  • adalimumab (Humira)
  • certolizumab (Cimzia)
  • golimumab (Simponi)
  • infliximab (Remicade)

Entyvio vs. Tunawa

Entyvio da Remicade (infliximab) duka sunaye ne masu magungunan ƙwayoyin cuta, amma suna cikin azuzuwan magunguna daban-daban. Entyvio na daga cikin nau'ikan magungunan da ake kira 'antinagon receptor antagonists'. Remicade na cikin ajin magungunan da ake kira tumor necrosis factor (TNF) -alpha inhibitors.

Yi amfani da

Entyvio da Remicade duk sun sami izinin FDA don magance cutar ta UC da Crohn. Hakanan an yarda da Remicade don magance wasu sharuɗɗa, gami da:

• rheumatoid amosanin gabbai
• psoriasis
• cututtukan zuciya na psoriatic
• ankylosing spondylitis

Sigogin ƙwayoyi

Dukansu Entyvio da Remicade suna wadatar azaman mafita don jigilar jijiyoyin jini (IV). Ana kuma gudanar da su a kan irin wannan jadawalin. Bayan allurai uku na farko, ana ba da waɗannan magungunan kowane mako takwas.

Sakamakon sakamako da kasada

Entyvio da Remicade suna da wasu illoli iri ɗaya, kuma wasu sun bambanta. Da ke ƙasa akwai misalai na waɗannan tasirin.

* Remicade yana da gargaɗin dambe daga FDA. Gargadi mai ban tsoro shine gargadi mafi karfi da FDA ke buƙata. Yana faɗakar da likitoci da marasa lafiya game da tasirin kwayoyi waɗanda zasu iya zama haɗari.

Inganci

Dukansu Entyvio da Remicade ana amfani dasu don magance cutar ta UC da Crohn. Amma Entyvio yawanci ana amfani dashi ne kawai don magance cutar ta UC da Crohn a cikin mutanen da basu da wadataccen ci gaba tare da wasu magunguna kamar Remicade.

Ba a kwatanta tasirin waɗannan magunguna kai tsaye a cikin nazarin asibiti. Koyaya, wasu masu bincike a cikin 2014 da 2016 sun gwada sakamako daga karatu daban-daban akan waɗannan magungunan.

Sharuɗɗa daga Gungiyar Gastroenterological Association ta Amurka sun ba da shawarar yin amfani da wakili na ilimin halittu kamar vedolizumab (magani mai aiki a cikin Entyvio) ko infliximab (ƙwaya mai aiki a cikin Remicade) don jawowa da ci gaba da gafartawa ga manya tare da matsakaici zuwa mai tsanani UC.

Sharuɗɗa daga Kwalejin Gastroenterology ta Amurka sun ba da shawarar duka vedolizumab (magani mai aiki a cikin Entyvio) da infliximab (magani mai aiki a cikin Remicade) don kula da manya tare da matsakaiciyar cuta mai tsanani na cutar Crohn.

Kudin

Kudin ko dai Entyvio ko Remicade na iya bambanta dangane da shirin maganinku. Ainihin farashin da zaku biya ko dai Entyvio ko Remicade ya dogara da tsarin inshorar ku, wurin ku, da kuma kantin da kuke amfani da shi. Don gano abin da kowane magani zai iya tsada a yankinku, ziyarci GoodRx.com.

Entyvio vs. Humira

Entyvio da Humira (adalimumab) duka sunaye ne masu magungunan ilimin halittu, amma suna cikin azuzuwan magunguna daban-daban. Entyvio na daga cikin nau'ikan magungunan da ake kira 'antinagon receptor antagonists'. Humira na cikin rukunin magungunan da ake kira tumor necrosis factor (TNF) - masu hana alpha.

Yana amfani da

Entyvio da Humira dukkansu an amince da FDA don magance ulcerative colitis (UC) da cutar Crohn. Humira kuma an yarda dashi don magance wasu sharuɗɗa, gami da:

• rheumatoid amosanin gabbai
• psoriasis
• cututtukan zuciya na psoriatic
• ankylosing spondylitis
• uveitis

Sigogin ƙwayoyi

Entyvio ta zo ne a matsayin mafita ga maganin cikin jini wanda aka bayar a ofishin likita. Bayan an yi allurai uku na farko, ana ba Entyvio sau ɗaya a kowane mako takwas.

Humira tazo ne a matsayin allurar subcutaneous. Wannan allura ce da ake yi a ƙarƙashin fata. Humira zata iya sarrafa kanta. Bayan makonni huɗu na farko, ana amfani da shi kowane mako.

Sakamakon sakamako da kasada

Entyvio da Humira suna da wasu illoli iri ɗaya, kuma wasu sun bambanta. Da ke ƙasa akwai misalai na waɗannan tasirin.

* Humira tana da gargaɗin dambe daga FDA. Wannan shine gargadi mafi karfi da FDA ke buƙata. Gargaɗin gargaɗi na faɗakarwa ga likitoci da marasa lafiya game da tasirin kwayoyi waɗanda na iya zama haɗari.

Inganci

Ana amfani da Entyvio da Humira don magance cutar ta UC da ta Crohn. Koyaya, ana amfani da Entyvio ne kawai ga mutanen da basu da wadataccen ci gaba ta amfani da wasu magunguna, kamar su Humira.

Ba a kwatanta tasirin waɗannan magunguna kai tsaye a cikin nazarin asibiti. Amma wasu nazarin daga 2014 da 2016 suna ba da wasu bayanan kwatancen.

Kudin

Kudin ko dai Entyvio ko Humira na iya bambanta dangane da shirin maganinku. Ainihin farashin da zaku biya ko dai Entyvio ko Humira ya dogara da tsarin inshorar ku, wurin ku, da kuma kantin da kuke amfani da shi. Don gano abin da kowane magani zai iya tsada a yankinku, ziyarci GoodRx.com.

Amfanin waɗannan magunguna don magance cutar Crohn ba a kwatanta kai tsaye a cikin nazarin asibiti. Koyaya, kwatancen da ba kai tsaye ba ya gano cewa Entyvio da Cimzia suna aiki daidai gwargwado don gafarar alamun a cikin mutanen da ba su taɓa amfani da ƙwayoyin maganin ba.

Entyvio da barasa

Entyvio baya hulɗa da barasa. Koyaya, shan giya na iya ɓata wasu tasirin tasirin Entyvio, kamar su:

• tashin zuciya
• ciwon kai
• hanci mai zafin gaske

Hakanan, yawan shan barasa na iya ƙara haɗarin cutar hanta daga Entyvio.

Yana da mahimmanci a lura cewa yin amfani da giya na iya kara ɓarke ​​wasu alamomin ulcerative colitis (UC) ko cutar Crohn. Wadannan alamun sun hada da:

• tashin zuciya
• amai
• zubar jini na ciki ko na hanji
• gudawa

Entyvio hulɗa

Entyvio na iya hulɗa tare da wasu magunguna da yawa.

Hanyoyi daban-daban na iya haifar da sakamako daban-daban. Misali, wasu na iya tsoma baki game da yadda kwayoyi ke aiki da kyau, yayin da wasu na iya haifar da ƙarin illa.

Entyvio da sauran magunguna

Da ke ƙasa akwai jerin magunguna waɗanda zasu iya hulɗa da Entyvio. Wannan jeren ba ya ƙunsar duk magungunan da zasu iya hulɗa da Entyvio.

Kafin shan Entyvio, ka tabbata ka gaya wa likitanka da likitan magunguna game da duk takardar sayen magani, kan-kan-kanta, da sauran magungunan da kake sha. Har ila yau, gaya musu game da kowane bitamin, ganye, da abubuwan da kuke amfani da su. Raba wannan bayanin na iya taimaka maka ka guji yiwuwar mu'amala.

Idan kuna da tambayoyi game da ma'amalar miyagun ƙwayoyi waɗanda zasu iya shafar ku, tambayi likitan ku ko likitan magunguna.

Magunguna waɗanda zasu iya hulɗa tare da Entyvio

Da ke ƙasa akwai misalan magunguna waɗanda za su iya hulɗa tare da Entyvio. Wannan jeren ba ya ƙunsar duk magungunan da zasu iya hulɗa da Entyvio.

• Tumor necrosis factor masu hanawa. Shan Entyvio tare da tumo necrosis factor inhibitors na iya kara barazanar kamuwa da ku. Misalan waɗannan kwayoyi sun haɗa da:
  • adalimumab (Humira)
  • certolizumab (Cimzia)
  • golimumab (Simponi)
  • infliximab (Remicade)
• Natalizumab (Tysabri). Shan Entyvio tare da natalizumab na iya kara haɗarin kamuwa da cutar ƙwaƙwalwa mai tsanani wanda ake kira m multifocal leukoencephalopathy (PML).

Entyvio da rigakafin rayuwa

Wasu maganin rigakafi suna ƙunshe da ƙwayoyin cuta masu aiki amma raunana. Wadannan galibi ana kiran su alurar riga kafi. Idan kun sha Entyvio, bai kamata ku sami rigakafin rayuwa ba. Waɗannan na iya haɓaka haɗarin kamuwa da cutar da ake nufin rigakafin. Misalan wadannan rigakafin sun hada da:

• allurar rigakafin mura ta hanci (FluMist)
• maganin rigakafin rotavirus (Rotateq, Rotarix)
• kyanda, mumps, rubella (MMR)
• maganin rigakafin kaza (Varivax)
• allurar rigakafin zazzaɓi (YF Vax)

Yadda ake shirya don jigilar Entyvio

Ana ba da Entyvio azaman jigilar jini (IV). Wannan yana nufin ana buƙatar a ba shi a cikin ofishin likitanku, asibiti, ko cibiyar jiko.

Kafin nadinku

Likitan ku ko likita zai ba ku takamaiman umarnin kan yadda za ku shirya don jiko, amma ga wasu nasihu:

• Sha ruwa. Tabbatar shan ruwa mai yawa kwana ɗaya ko biyu kafin haɗuwa da jiko. Ga yawancin mutane, wannan ya zama gilashin ruwa shida ko takwas a rana. Yi ƙoƙari ka guji yawan shan maganin kafeyin, wanda zai iya haifar da asarar ruwa.
• Faɗa wa likitanka. Idan kana da alamun kamuwa da cuta, kamar tari ko zazzabi, ka tabbata ka sanar da likitanka. Har ila yau, gaya wa likitanka idan kana shan maganin rigakafi. A kowane hali, kuna iya sake tsara jaddawarku game da shigar jakar ku.
• Iso da wuri. Don shigarwar ku ta farko, yi shirin isa mintuna 15 zuwa 20 da wuri don kammala takardu, idan an buƙata.
• Zo a shirya. Wannan ya hada da:
• Miya a cikin yadudduka. Wasu mutane suna jin sanyi yayin karɓar jiko.
• Kawo abun ciye ciye ko abincin rana. Kodayake infusions ba su daɗe sosai, kuna so ku ci idan kuna da jiko a kan lokacin cin abincin ku na rana.
• Kawo na'urarku ta hannu, belun kunne, ko littafi idan kuna son nishaɗi yayin jigilar.
• Sanin jadawalin ku. Idan kuna da hutu mai zuwa ko wasu lokuta ba zaku samu ba, alƙawarinku lokaci ne mai kyau don kammala kwanakin jiko na gaba.

Abin da ake tsammani

• A lokacin nadin ka, za ka karɓi IV. Da zarar an saka IV a cikin jijiyar ku, jigon kansa yawanci yakan ɗauki kimanin minti 30.
• Da zarar an kammala jiko, zaku iya komawa bakin aiki ko ayyukan yau da kullun. Wasu mutane suna da lahani mai sauƙi bayan jiko, kamar su:
• taushi ko rauni a wurin IV
• sanyi-kamar bayyanar cututtuka
• ciwon kai
• gajiya
• tashin zuciya
• ciwon gwiwa
• kurji

Wadannan cututtukan suna yawan wucewa cikin kwana daya ko biyu. Idan basu tafi ba, kira likitan ku.Idan ka samo alamun bayyanar rashin lafiyan, kamar matsalar numfashi ko kumburin fuska, lebe, ko baki, kira 911 ko kuma wani ya dauke ka zuwa dakin gaggawa.

Ta yaya Entyvio ke aiki

Kwayar cututtukan cututtuka na ulcerative colitis (UC) da cutar Crohn ana haifar da kumburi a cikin hanji. Wannan kumburin yana faruwa ne sanadiyyar motsin wasu kwayoyin jini a cikin hanji (hanji).

Tsarin Entyvio na aiki shi ne cewa yana toshe wasu daga cikin alamun da ke haifar da wadannan fararen kwayoyin halittar jinin su motsa cikin hanji. Wannan aikin na iya rage kumburi da sauran alamun cutar UC da cutar Crohn.

Entyvio da ciki

Babu wani karatu a cikin mutane da ya kimanta ko Entyvio tana da lafiya don amfani yayin ciki. Karatun dabbobi ba su sami wata illa ba, amma karatu a cikin dabbobi ba koyaushe ke hango abin da zai faru a cikin mutane ba.

Idan akwai haɗari ga ɗan tayi, zai iya zama mafi girma yayin watanni uku da na uku. A wannan lokacin, da alama ɗan tayin zai iya fuskantar ƙarin maganin.

Idan kana shan Entyvio kuma kana da ciki ko kuma tunanin yin ciki, yi magana da likitanka. Zasu iya gaya muku game da haɗari da fa'idodi na ci gaba da maganinku na Entyvio ko dakatar da shi.

Idan kun karɓi Entyvio yayin da kuke da ciki, zaku iya yin rajista don yin rajista wanda zai taimaka tattara bayanai game da kwarewarku. Rijistar ɗaukar ciki ta taimaka wa ƙwararrun likitocin kiwon lafiya ƙarin koyo game da yadda wasu ƙwayoyi ke shafar mata da juna biyu. Don yin rajista, kira 877-825-3327.

Entyvio da nono

Ntyananan Entyvio suna cikin ruwan nono. Koyaya, karatuttukan karatu basu sami wata illa ba akan yaran da uwaye ke shayar dasu Entyvio.

Idan kuna karɓar Entyvio kuma kuna so ku shayar da yaro, kuyi magana da likitanku game da haɗarin hakan.

Tambayoyi gama gari game da Entyvio

Anan akwai amsoshi ga wasu tambayoyin da akai akai game da Entyvio.

Shin Entyvio ilimin halittu ne?

Haka ne, Entyvio magani ne na ilimin halittu. Ana yin ilimin ilimin halittu daga asalin halitta, kamar ƙwayoyin rai.

Har yaushe Entyvio ke aiki?

Jiyya tare da Entyvio ya kasu kashi biyu. Ana ba da allurai uku na farko da aka fara yayin lokacin shigarwar, wanda ya ɗauki tsawon makonni shida. A wannan lokacin, ana ba da kashi na biyu makonni biyu bayan na farko da aka sha. Ana ba da kashi na uku bayan sati huɗu bayan an sha kashi na biyu.

Kodayake bayyanar cututtuka na iya fara inganta nan da nan bayan jigilar farko, yana iya ɗaukar tsawon makonni shida don samun alamun alamun a ƙarƙashin iko.

Lokacin gyarawa yana biye da lokacin shigarwa. Yayin lokacin kulawa, ana ba da allurai kowane mako takwas don ci gaba da bayyanar cututtuka.

Shin za ku iya ɗaukar Entyvio idan kuna yin tiyata?

Idan kana da aikin tiyata, gami da tiyatar hakori, mai yiwuwa ka buƙaci jinkirta ko sake tsara jadawalin shigar Entyvio.

Gargadin Entyvio

Kafin ɗaukar Entyvio, yi magana da likitanka game da duk wani yanayin lafiyar da kake da shi. Entyvio bazai dace da kai ba idan kana da wasu yanayin lafiya.

• Ga mutanen da ke da cuta: Entyvio na iya kara kamuwa da cututtuka. Idan kana da alamun kamuwa da cuta, kamar zazzaɓi ko tari, mai yiwuwa ba za ka iya amfani da Entyvio ba har sai cutar ta warke.
• Ga mutanen da ke da cutar hanta: Entyvio na iya kara matsalar hanta ga wadanda suka riga sun kamu da cutar hanta. Hakanan yana iya haifar da lalacewar hanta.

Bayanin sanarwa:Labaran Likita A Yau yayi iya ƙoƙari don tabbatar da cewa dukkan bayanai gaskiyane, ingantattu, kuma ingantattu. Koyaya, wannan labarin bai kamata ayi amfani dashi azaman madadin ilimi da ƙwarewar ƙwararren likita mai lasisi ba. Ya kamata koyaushe ku tuntuɓi likitanku ko wasu masu sana'a na kiwon lafiya kafin shan kowane magani. Bayanin magani da ke cikin wannan batun na iya canzawa kuma ba ana nufin ya rufe duk amfanin da zai yiwu ba, kwatance, kiyayewa, gargaɗi, hulɗar miyagun ƙwayoyi, halayen rashin lafiyan, ko cutarwa. Rashin gargadin ko wasu bayanai don maganin da aka bayar baya nuna cewa magani ko haɗin magungunan yana da aminci, tasiri, ko dacewa ga duk marasa lafiya ko duk takamaiman amfani.